Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amgen

Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen

Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the eyes to swell.

Investors Business Daily

Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?

Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?

Results for Amgen's weight loss drug Maritide were highly anticipated, but fell short. However, MariTide could still turn the tables in future studies.

Is Amgen Stock Underperforming the Dow?

Is Amgen Stock Underperforming the Dow?

Despite pharma giant Amgen trailing behind the Dow index over the past three months, analysts remain cautiously bullish about the stock's growth potential.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Wide Trading Range For Amgen Stock Makes This Option Shine

Even though Amgen is weak below the 200-day line, there's still a way to profit.

Investors Business Daily

3 Biotech Stocks with Promising Pipelines to Watch

As breakthroughs in biotechnology accelerate, the sector is primed for significant expansion. With emerging trends like gene editing and precision medicine transforming healthcare, fundamentally solid biotech stocks such as Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) are gaining traction. With promising innovations, these stocks could be prime investment opportunities.…

Stock Market Hits Highs Despite Trump Tariff Threats, Nvidia, Tech Turkeys: Weekly Review

Most indexes hit new highs during Thanksgiving week despite President-elect Trump's tariff threats. Nvidia woes helped curb the Nasdaq's gains.

Investors Business Daily

Stock Market Today: The S&P 500 Reclaims the 6K Level

Investors see Scott Bessent as a safe shepherd of the economy as the president-elect burnishes his "Tariff Man" reputation.

inkl

Read news from The Economist, FT, and more,
with one subscription

Stocks Gain on Positive Corporate News and a Jump in US Consumer Confidence

Stocks Gain on Positive Corporate News and a Jump in US Consumer Confidence

The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.45%. Stocks today are mixed, with some positive corporate news lifting the broader market. JM...

Dow Jones, S&P 500 At New High After Fed Minutes; Dell, Workday, CrowdStrike Report (Live Coverage)

Dow Jones, S&P 500 At New High After Fed Minutes; Dell, Workday, CrowdStrike Report (Live Coverage)

The Dow Jones Industrial Average fell after news that President-elect Trump may impose tariffs on goods from China, Mexico and Canada.

Investors Business Daily

Stocks Climb on Positive Corporate News

Stocks Climb on Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.48%. Stocks today are mixed, with some positive corporate news lifting the broader market. JM...

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment

Amgen stock tumbled Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's Zepbound.

Investors Business Daily

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

Amgen's Phase 2 MariTide trial showed ~20% weight loss at 52 weeks, cardiometabolic improvements, and no significant safety issues.

Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage.

Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage.

With the recent spike in implied volatility, an iron condor on Amgen can use short strikes with a wide profit range.

Investors Business Daily

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?

Amgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot causes excessive bone mineral density loss.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Amgen Drops 7% After A 'Big Unknown Risk' Rattles Its Monthly Obesity Shot

Amgen stock tumbled late Tuesday on a report its high-profile weight-loss shot, MariTide, could be linked to bone mineral density loss.

Investors Business Daily

Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO

Amgen is focusing deeply on its efforts to treat obesity, the CFO said Wednesday. Amgen stock rose early Thursday.

Investors Business Daily

Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.

Pfizer is taking on Amgen with its next steps in weight loss, the pharma titan said Tuesday as Pfizer stock dipped despite its beat.

3 Top Healthcare Stocks to Buy for Growth and Dividends

Investors seeking growth and dividend income in the healthcare sector may want to consider Eli Lilly, Gilead Sciences, and Amgen, which have delivered impressive returns and boast strong pipelines and strategic moves.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade

Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already baked into the stock.

Investors Business Daily

Dow Jones Rises After Inflation Data; Tesla Plunges On Robotaxi Event

Stock Market Today: The Dow Jones rose Friday after key inflation data. Tesla stock plunged after its Robotaxi event.

Investors Business Daily

How To Invest: Biotechs Can Make Huge Gains But Have Unique Risks

In some cases, biotechs go public without having even a single product on the market.

Investors Business Daily

Dow Jones Falls On Hot Inflation Data; Tesla Slides Ahead Of Robotaxi Event

Stock Market Today: The Dow Jones dropped Thursday on a hot inflation report. Tesla skidded before its Robotaxi event.

Investors Business Daily

Dow Jones Rallies On Strong Jobs Report; Nvidia Nears Buy Point

Stock Market Today: The Dow Jones rallied Friday on a strong September jobs report. Nvidia stock is nearing a new buy point.

Investors Business Daily

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Investors Business Daily

Stock Market Rally Hits Fresh Highs, Fueled By Micron Earnings, China Stimulus: Weekly Review

The stock market rally extended its advance, with the S&P 500 hitting record highs, fueled by Micron and Chinese stimulus.

People

110,033 stories

Mark Zuckerberg

Kritika SarmahHer

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

the Justice Department

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

264,602 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play